Understanding the Side Effects, Dangers, and Complications of Gentamycin

Introduction Gentamycin is a commonly prescribed antibiotic that belongs to the class of drugs known as aminoglycosides. It is primarily used to treat serious bacterial infections, particularly those caused by gram-negative bacteria. While gentamycin is an effective medication, it is important to be aware of the potential side effects, dangers, and complications that can arise […]

Understanding the Side Effects, Dangers, and Complications of Gentamycin Read More »

red and white stop sign

Long-Term Effects of COVID-19 and the Challenges Ahead

COVID-19, caused by the novel coronavirus, has had a profound impact on the world. While the immediate health effects of the virus are well-known, there is growing concern about the long-term effects that COVID-19 may have on individuals and society as a whole. In this article, we will explore the potential long-term consequences of COVID-19

Long-Term Effects of COVID-19 and the Challenges Ahead Read More »

doctor sitting on desk talking to sitting woman

Quantitative Neuro Muscular Monitoring: Enhancing Patient Care

Quantitative neuro muscular monitoring is a valuable tool in the field of healthcare that aids in assessing and managing patients’ neuromuscular function. It provides clinicians with crucial information about the strength and function of muscles, allowing for more accurate diagnoses and better treatment plans. This article will explore the various applications and benefits of quantitative

Quantitative Neuro Muscular Monitoring: Enhancing Patient Care Read More »

Lantus use in ICU

Lantus is a long-acting insulin analogue also known as insulin glargine. Lantus use in ICU is described in detail here. Similar to human insulin, it is produced using recombinant DNA techniques. Insulin glargine substitutes glycine for asparagine at position A21 of the insulin molecule and adds two arginine molecules at position B30. The isoelectric point

Lantus use in ICU Read More »

Hyperglycemia in the intensive care unit

Hyperglycemia and insulin resistance are common in critically ill patients even if they did not have diabetes before their illnesses. Hyperglycemia in the intensive care unit (ICU) setting has been shown to be associated with an increased mortality, and restoration of nor-moglycemia using intensive insulin therapy has decreased mortality for the following populations:myocardial infarction, burn,

Hyperglycemia in the intensive care unit Read More »

Diabetes in ICU

For managing Diabetes in ICU, maintaining euglycemia (defined as glucose <110 mg/dL in intensive care unit settings and <180 mg/dL in non intensive care unit settings by American College of Endocrinology Consensus Guidelines) has been shown to greatly reduce morbidity and mortality. This has created a paradigm shift in the inpatient setting where the goal

Diabetes in ICU Read More »

Erythromycin prokinetic agent

Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis and is effective against the same organisms as penicillin G. The drug is commonly used to treat community-acquired pulmonary infections in penicillin-allergic patients. Erythromycin also has prokinetic effects on the gastrointestinal system. At low doses, erythromycin prokinetic agent induces activity in the gastric antrum, which

Erythromycin prokinetic agent Read More »

Scroll to Top